Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Testing effectiveness (Phase 2)Looking for participantsNCT05482893
What this trial is testing

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)
Phanes Therapeutics 258
Testing effectiveness (Phase 2)Ended earlyNCT00881621
What this trial is testing

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Who this might be right for
Pancreas Cancer
Georgetown University 17
Large-scale testing (Phase 3)Study completedNCT00789633
What this trial is testing

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AB Science 353
Testing effectiveness (Phase 2)UnknownNCT02461836
What this trial is testing

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 513
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683221
What this trial is testing

SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shandong Cancer Hospital and Institute 47
Testing effectiveness (Phase 2)Study completedNCT01821729
What this trial is testing

Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00114179
What this trial is testing

Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
National Cancer Institute (NCI) 82
Testing effectiveness (Phase 2)Study completedNCT00031694
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT00024427
What this trial is testing

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganPancreatic Cancer
Wellstat Therapeutics 250
Testing effectiveness (Phase 2)Study completedNCT03138720
What this trial is testing

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Who this might be right for
Resectable Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma+1 more
HonorHealth Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Large-scale testing (Phase 3)Study completedNCT00471146
What this trial is testing

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Who this might be right for
Carcinoma, Pancreatic Ductal
Pfizer 630
Early research (Phase 1)Active Not RecruitingNCT04484909
What this trial is testing

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 24
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Testing effectiveness (Phase 2)WithdrawnNCT01017822
What this trial is testing

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578337
What this trial is testing

A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.

Who this might be right for
UntreatedAdvanced Pancreatic Cancer
Nelum Corp 40
Not applicableAvailableNCT01786850
What this trial is testing

Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
PancreasCancerLocally Advanced Pancreatic Cancer+1 more
University of Roma La Sapienza
Next Page